289 related articles for article (PubMed ID: 37449556)
1. Mediators and mechanisms of immune checkpoint inhibitor-associated myocarditis: Insights from mouse and human.
Gong J; Neilan TG; Zlotoff DA
Immunol Rev; 2023 Sep; 318(1):70-80. PubMed ID: 37449556
[TBL] [Abstract][Full Text] [Related]
2. Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity.
Wang Y; Ertl C; Schmitt C; Hammann L; Kramer R; Grabmaier U; Schöberl F; Anz D; Piseddu I; Pesch G; Vera J; Froehlich W; Weckbach L; Tomsitz D; Loquai C; Zimmer L; Mangana J; Dummer R; Gutzmer R; Klespe KC; Stege H; Meiss F; Thoms KM; Terheyden P; Bröckelmann PJ; Johnson DB; French LE; Heinzerling L
Front Cardiovasc Med; 2024; 11():1408586. PubMed ID: 38915743
[TBL] [Abstract][Full Text] [Related]
3. Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor.
Blum SM; Zlotoff DA; Smith NP; Kernin IJ; Ramesh S; Zubiri L; Caplin J; Samanta N; Martin SC; Tirard A; Sen P; Song Y; Barth J; Slowikowski K; Nasrallah M; Tantivit J; Manakongtreecheep K; Arnold BY; McGuire J; Pinto CJ; McLoughlin D; Jackson M; Chan P; Lawless A; Sharova T; Nieman LT; Gainor JF; Juric D; Mino-Kenudsen M; Sullivan RJ; Boland GM; Stone JR; Thomas MF; Neilan TG; Reynolds KL; Villani AC
bioRxiv; 2023 Nov; ():. PubMed ID: 37790460
[TBL] [Abstract][Full Text] [Related]
4. Identification of Pathogenic Immune Cell Subsets Associated With Checkpoint Inhibitor-Induced Myocarditis.
Zhu H; Galdos FX; Lee D; Waliany S; Huang YV; Ryan J; Dang K; Neal JW; Wakelee HA; Reddy SA; Srinivas S; Lin LL; Witteles RM; Maecker HT; Davis MM; Nguyen PK; Wu SM
Circulation; 2022 Jul; 146(4):316-335. PubMed ID: 35762356
[TBL] [Abstract][Full Text] [Related]
5. Multi-organ Immune-Related Adverse Event Is a Risk Factor of Immune Checkpoint Inhibitor-Associated Myocarditis in Cancer Patients: A Multi-center Study.
Xie X; Wang L; Li Y; Xu Y; Wu J; Lin X; Lin W; Mai Q; Chen Z; Zhang J; Xie Z; Qin Y; Liu M; Lu M; Luo B; Zhou C
Front Immunol; 2022; 13():879900. PubMed ID: 35924238
[TBL] [Abstract][Full Text] [Related]
6. Cardiac myosin-specific autoimmune T cells contribute to immune-checkpoint-inhibitor-associated myocarditis.
Won T; Kalinoski HM; Wood MK; Hughes DM; Jaime CM; Delgado P; Talor MV; Lasrado N; Reddy J; Čiháková D
Cell Rep; 2022 Nov; 41(6):111611. PubMed ID: 36351411
[TBL] [Abstract][Full Text] [Related]
7. Immune checkpoint inhibitor-associated myocarditis: manifestations and mechanisms.
Moslehi J; Lichtman AH; Sharpe AH; Galluzzi L; Kitsis RN
J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33645548
[TBL] [Abstract][Full Text] [Related]
8. Cardiotoxicity of Immune Checkpoint Inhibitors.
Patel RP; Parikh R; Gunturu KS; Tariq RZ; Dani SS; Ganatra S; Nohria A
Curr Oncol Rep; 2021 May; 23(7):79. PubMed ID: 33937956
[TBL] [Abstract][Full Text] [Related]
9. ANGPTL2 promotes immune checkpoint inhibitor-related murine autoimmune myocarditis.
Horiguchi H; Kadomatsu T; Yamashita T; Yumoto S; Terada K; Sato M; Morinaga J; Miyata K; Oike Y
Commun Biol; 2023 Sep; 6(1):965. PubMed ID: 37736764
[TBL] [Abstract][Full Text] [Related]
10. [Research Progress of Immune Checkpoint Inhibitor-associated Myocarditis].
Liu Y; Chen Y; Zeng Z; Liu A
Zhongguo Fei Ai Za Zhi; 2021 Sep; 24(9):668-672. PubMed ID: 34521189
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors for Immune Checkpoint Inhibitor-Mediated Cardiovascular Toxicities.
Yousif LI; Screever EM; Versluis D; Aboumsallem JP; Nierkens S; Manintveld OC; de Boer RA; Meijers WC
Curr Oncol Rep; 2023 Jul; 25(7):753-763. PubMed ID: 37079251
[TBL] [Abstract][Full Text] [Related]
12. Heart-Specific Immune Responses in an Animal Model of Autoimmune-Related Myocarditis Mitigated by an Immunoproteasome Inhibitor and Genetic Ablation.
Bockstahler M; Fischer A; Goetzke CC; Neumaier HL; Sauter M; Kespohl M; Müller AM; Meckes C; Salbach C; Schenk M; Heuser A; Landmesser U; Weiner J; Meder B; Lehmann L; Kratzer A; Klingel K; Katus HA; Kaya Z; Beling A
Circulation; 2020 Jun; 141(23):1885-1902. PubMed ID: 32160764
[TBL] [Abstract][Full Text] [Related]
13. TNF-α Inhibitors and Other Biologic Agents for the Treatment of Immune Checkpoint Inhibitor-Induced Myocarditis.
Liu X; Wu W; Fang L; Liu Y; Chen W
Front Immunol; 2022; 13():922782. PubMed ID: 35844550
[TBL] [Abstract][Full Text] [Related]
14. Clinical manifestation and management of immune checkpoint inhibitor-associated cardiotoxicity.
Guo X; Wang H; Zhou J; Li Y; Duan L; Si X; Zhang L; Fang L; Zhang L
Thorac Cancer; 2020 Feb; 11(2):475-480. PubMed ID: 31849171
[TBL] [Abstract][Full Text] [Related]
15. Major Adverse Cardiac Events With Immune Checkpoint Inhibitors: A Pooled Analysis of Trials Sponsored by the National Cancer Institute-Cancer Therapy Evaluation Program.
Naqash AR; Moey MYY; Cherie Tan XW; Laharwal M; Hill V; Moka N; Finnigan S; Murray J; Johnson DB; Moslehi JJ; Sharon E
J Clin Oncol; 2022 Oct; 40(29):3439-3452. PubMed ID: 35658474
[TBL] [Abstract][Full Text] [Related]
16. An Emergent Form of Cardiotoxicity: Acute Myocarditis Induced by Immune Checkpoint Inhibitors.
Esposito R; Fedele T; Orefice S; Cuomo V; Prastaro M; Canonico ME; Ilardi F; De Stefano F; Fiorillo L; Santoro C; Esposito G
Biomolecules; 2021 May; 11(6):. PubMed ID: 34067474
[TBL] [Abstract][Full Text] [Related]
17. T cells specific for α-myosin drive immunotherapy-related myocarditis.
Axelrod ML; Meijers WC; Screever EM; Qin J; Carroll MG; Sun X; Tannous E; Zhang Y; Sugiura A; Taylor BC; Hanna A; Zhang S; Amancherla K; Tai W; Wright JJ; Wei SC; Opalenik SR; Toren AL; Rathmell JC; Ferrell PB; Phillips EJ; Mallal S; Johnson DB; Allison JP; Moslehi JJ; Balko JM
Nature; 2022 Nov; 611(7937):818-826. PubMed ID: 36385524
[TBL] [Abstract][Full Text] [Related]
18. A case of subclinical immune checkpoint inhibitor-associated myocarditis in non-small cell lung cancer.
Hu Y; Liu C; Jin S; Yi Z; Wang C; Pan X; Huang H
BMC Pulm Med; 2023 Apr; 23(1):119. PubMed ID: 37060029
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of low-intensity pulsed ultrasound on immune checkpoint inhibitor-related myocarditis via fine-tuning CD4
Fu S; Guo Z; Xu X; Li Y; Choi S; Zhao P; Shen W; Gao F; Wang C; Chen S; Li Y; Tian J; Sun P
Cancer Immunol Immunother; 2024 Jan; 73(1):15. PubMed ID: 38236243
[TBL] [Abstract][Full Text] [Related]
20. Immune Checkpoint Inhibitors Mediated Lymphocytic and Giant Cell Myocarditis: Uncovering Etiological Mechanisms.
Rikhi R; Karnuta J; Hussain M; Collier P; Funchain P; Tang WHW; Chan TA; Moudgil R
Front Cardiovasc Med; 2021; 8():721333. PubMed ID: 34434981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
